Literature DB >> 16236130

The frequency of double-positive thymocytes expressing an alphabeta TCR clonotype regulates peripheral CD4 T cell compartment homeostasis.

Amy J Reed1, Yasaman Zarrabi, Alison L Perate, Arjun Jeganathan, Ali Naji, Hooman Noorchashm.   

Abstract

The present study aimed to determine whether the frequency of double positive (DP) thymocytes expressing alphabeta T-cell receptor (TCR) clonotypes at the time of selection regulates peripheral CD4 T-cell compartment size. Scid recipients were inoculated with various ratios of TCR Calpha(0/0) and wild-type bone marrow (BM) stem cells. Increasing the frequency of TCR Calpha(0/0) thymocytes at steady-state introduced a graded decrease in the maturation probability of the total DP thymocyte pool. At 12-14 weeks following BM inoculation, the frequency of TCR Calpha(0/0) DP thymocytes was inversely correlated with that of CD4 single positive (SP) thymocytes. Notwithstanding, a decreased frequency of wild-type DP thymocytes led to a marked increase in their transit efficiency from the DP to SP compartments. The frequency-dependent increase in thymocyte transit efficiency was associated with a CD4 SP cell surface phenotype indicative of increased antigenic experience. Importantly, the frequency of DP thymocytes capable of expressing TCR clonotypes dictated the steady-state size of the peripheral CD4 T cell compartment and its potential for homeostatic proliferation. Collectively, these results indicate that the efficiency of DP to CD4 SP transit is a frequency dependent process, which determines (1) the steady-state size of the peripheral T cell compartment and (2) the threshold for homeostatic expansion of peripheral CD4 T cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16236130      PMCID: PMC1802421          DOI: 10.1111/j.1365-2567.2005.02240.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  20 in total

1.  IL-7 is critical for homeostatic proliferation and survival of naive T cells.

Authors:  J T Tan; E Dudl; E LeRoy; R Murray; J Sprent; K I Weinberg; C D Surh
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-10       Impact factor: 11.205

2.  T lymphocytes need IL-7 but not IL-4 or IL-6 to survive in vivo.

Authors:  L Vivien; C Benoist; D Mathis
Journal:  Int Immunol       Date:  2001-06       Impact factor: 4.823

Review 3.  Cytokines and T cell homeostasis.

Authors:  Jonathan Sprent; Charles D Surh
Journal:  Immunol Lett       Date:  2003-01-22       Impact factor: 3.685

4.  Cutting edge: homeostatic proliferation of peripheral T lymphocytes is regulated by clonal competition.

Authors:  Amy E Troy; Hao Shen
Journal:  J Immunol       Date:  2003-01-15       Impact factor: 5.422

5.  The influence of the thymic environment on the CD4-versus-CD8 T lineage decision.

Authors:  Matilde Canelles; Melissa L Park; Owen M Schwartz; B J Fowlkes
Journal:  Nat Immunol       Date:  2003-07-13       Impact factor: 25.606

6.  Deadbeat neighbors influence thymocyte lineage commitment.

Authors:  Pamela J Fink
Journal:  Nat Immunol       Date:  2003-08       Impact factor: 25.606

7.  Peripheral selection of the T cell repertoire.

Authors:  B Rocha; H von Boehmer
Journal:  Science       Date:  1991-03-08       Impact factor: 47.728

8.  The stable and permanent expansion of functional T lymphocytes in athymic nude rats after a single injection of mature T cells.

Authors:  E B Bell; S M Sparshott; M T Drayson; W L Ford
Journal:  J Immunol       Date:  1987-09-01       Impact factor: 5.422

9.  Peripheral T lymphocytes: expansion potential and homeostatic regulation of pool sizes and CD4/CD8 ratios in vivo.

Authors:  B Rocha; N Dautigny; P Pereira
Journal:  Eur J Immunol       Date:  1989-05       Impact factor: 5.532

10.  Interleukin 15 controls both proliferation and survival of a subset of memory-phenotype CD8(+) T cells.

Authors:  Adam D Judge; Xiaohong Zhang; Hideki Fujii; Charles D Surh; Jonathan Sprent
Journal:  J Exp Med       Date:  2002-10-07       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.